Paolini John F. bought KNSA
March 2, 2026 · Form 4 insider transaction
Paolini John F. bought 40,000 shares of Kiniksa Pharmaceuticals International, plc at $10.36 per share, a transaction worth $414.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$10.36
Total value
$414.4K
InsiderPaolini John F.
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after101,324
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.